With strong co-existing relationships with all Phase 1 units across Australia.
Supporting our global client portfolio with over 20 years’ experience.
World class reputation for accuracy, precision and quality data sets.
The Australian Regulatory Framework is the fastest in the world for undertaking early phase clinical trials.
At Avance Clinical, we have over 20 years’ experience in offering seamless end-to-end in-house clinical research services, supporting our global client portfolio with clinical project management, trial monitoring, local safety reporting, medical writing, data management, statistical and pharmacokinetic services, CDISC and external and internal auditing.
As a leading Australian CRO, with extensive experience across all phases of clinical research, complemented with our full suite of in-house clinical research services, we can ensure your trials are delivered on time and on budget as a certified contract research organisation.
Avance Clinical Wins Frost & Sullivan “2020 Asia-Pacific CRO Market Leadership Award
“Within Asia-Pacific’s highly competitive CRO market, Avance Clinical stands out as a leader in early phase biotech clinical trials.
The company offers a highly responsive and proactive service for biotechs wanting rapid and innovative clinical trial solutions, with the highest level of data compliance. Avance Clinical offers a real size match for biotechs that means better mission understandings and stronger customer service compared to some of the larger CROs.”
Nidhi Jalali,
Analyst Best Practices, Frost & Sullivan
“We aim to give clients unparalleled service to optimise the timely and cost effective completion of projects. It’s as simple as that”
Yvonne Lungershausen,
Chief Executive Officer
It is our pleasure to announce that Mike Watson has joined the Avance Clinical team as Director Business Development, USA.
Based in Raleigh North Carolina, Mike is a seasoned business development professional having spent the past 12 years in the clinical research space.
The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical, joins Medrio’s new podcast series Trial Talks. Trial Talks season 1, episode 1 “Why Clinical Trials are Thriving in Australia” focuses on how Avance Clinical prepared for the pandemic, what tools were leveraged that allowed trial continuation, and why clinical trials are currently thriving in the region.
The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been contracted to conduct a clinical study of Atossa Therapeutics’ proprietary drug candidate AT-301, to be administered by nasal spray. Avance has successfully completed multiple clinical studies of Atossa’s proprietary Endoxifen.